Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.
2.

Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Mazella J, Botto JM, Guillemare E, Coppola T, Sarret P, Vincent JP.

J Neurosci. 1996 Sep 15;16(18):5613-20.

3.

Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.

Perron A, Sarret P, Gendron L, Stroh T, Beaudet A.

J Biol Chem. 2005 Mar 18;280(11):10219-27. Epub 2005 Jan 6.

4.

Molecular cloning of a levocabastine-sensitive neurotensin binding site.

Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J, Delpech B, Le Fur G, Ferrara P, Caput D.

FEBS Lett. 1996 May 20;386(2-3):91-4.

5.
6.

Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization.

Lépée-Lorgeoux I, Betancur C, Rostène W, Pélaprat D.

Brain Res Dev Brain Res. 1999 Mar 12;113(1-2):115-31.

PMID:
10064881
7.
8.

Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.

Nouel D, Faure MP, St Pierre JA, Alonso R, Quirion R, Beaudet A.

J Neurosci. 1997 Mar 1;17(5):1795-803.

9.

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.

Vita N, Oury-Donat F, Chalon P, Guillemot M, Kaghad M, Bachy A, Thurneyssen O, Garcia S, Poinot-Chazel C, Casellas P, Keane P, Le Fur G, Maffrand JP, Soubrie P, Caput D, Ferrara P.

Eur J Pharmacol. 1998 Nov 6;360(2-3):265-72.

PMID:
9851594
10.

The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.

Gutnisky A, López Ordieres MG, Rodríguez de Lores Arnaiz G.

Neurochem Res. 2016 Jun;41(6):1274-80. doi: 10.1007/s11064-015-1823-7. Epub 2016 Jan 7.

PMID:
26738992
11.

Genetic-based differences in neurotensin levels and receptors in brains of LS x SS mice.

Erwin VG, Radcliffe R, Hinkle B, Jones BC.

Peptides. 1993 Jul-Aug;14(4):821-8.

PMID:
8234031
12.
13.

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.

Vita N, Laurent P, Lefort S, Chalon P, Dumont X, Kaghad M, Gully D, Le Fur G, Ferrara P, Caput D.

FEBS Lett. 1993 Feb 8;317(1-2):139-42.

14.

Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin.

Navarro V, Martin S, Sarret P, Nielsen MS, Petersen CM, Vincent J, Mazella J.

FEBS Lett. 2001 Apr 20;495(1-2):100-5.

15.

Changes in expression levels of neurotensin precursor and receptor mRNA in chicken intestinal tissues and liver during late embryonic and early posthatching development.

Tanaka M, Nakao N, Yamamoto I, Tsushima N, Ohta Y.

Poult Sci. 2013 Oct;92(10):2765-71. doi: 10.3382/ps.2012-02939.

PMID:
24046425
16.

Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.

Schotte A, Leysen JE, Laduron PM.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):400-5.

PMID:
3022160
17.

Pharmacological and molecular characterization of the neurotensin receptor expressed in Sf9 cells.

Boudin H, Labrecque J, Lhiaubet AM, Dennis M, Rostène W, Pélaprat D.

Biochem Pharmacol. 1996 May 3;51(9):1243-6.

PMID:
8645349
18.

The partial agonist properties of levocabastine in neurotensin-induced analgesia.

Dubuc I, Remande S, Costentin J.

Eur J Pharmacol. 1999 Sep 17;381(1):9-12.

PMID:
10528128
19.
20.

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, et al.

Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65-9.

Supplemental Content

Support Center